1303973-24-1

Basic information

• Product Name: tert-butyl 4,4-difluoro-3-(hydroxyMethyl)piperidine-1-carboxylate
• Synonyms: tert-butyl 4,4-difluoro-3-(hydroxyMethyl)piperidine-1-carboxylate
• CAS NO: 1303973-24-1
• Molecular Formula: C₁₁H₁₉F₂NO₃
• Molecular Weight: 251.2702664
• Mol File: 1303973-24-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4,4-difluoro-3-(hydroxyMethyl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4,4-difluoro-3-(hydroxyMethyl)piperidine-1-carboxylate(1303973-24-1)
• EPA Substance Registry System: tert-butyl 4,4-difluoro-3-(hydroxyMethyl)piperidine-1-carboxylate(1303973-24-1)

Safety Data

• Hazardous Substances Data: 1303973-24-1(Hazardous Substances Data)

Usage

General Description

"Tert-butyl 4,4-difluoro-3-(hydroxyMethyl)piperidine-1-carboxylate" is a chemical compound with a complex and specific structure. It contains a tert-butyl group, a 4,4-difluoro-3-(hydroxyMethyl)piperidine core, and a carboxylate functional group. tert-butyl 4,4-difluoro-3-(hydroxyMethyl)piperidine-1-carboxylate is commonly used in organic synthesis and medicinal chemistry. It may have potential applications in pharmaceuticals and agrochemicals due to its unique structure and properties. However, further research and testing are necessary to fully understand and utilize the potential of this compound.

Upstream product

• 1303973-25-2 [4,4-difluoro-1-(phenylmethyl)-3-piperidinyl]methanol 
• 1303974-56-2 ethyl 4,4-difluoro-1-(phenylmethyl)-3-piperidinecarboxylate 
• 41276-30-6 C₉H₁₄O₃NC₆H₅ 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1331823-62-1 (4,4-difluoro-3-piperidyl)methanol 
• 1331775-99-5 (4,4-difluoropiperidin-3-yl)methanol hydrochloride 

Downstream Products

• 1331776-00-1 3-[6-butyl-5-(4-cyclohexyloxyphenyl)pyridazin-3-yloxymethyl]-4,4-difluoro-piperidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS

A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (Syk) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory disease and/or allergic disorders, and in cancer therapy, specifically heme malignancies, and autoimmune conditions.

PHENYL-HETEROARYL DERIVATIVES AND METHODS OF USE THEREOF

The present invention provides phenyl-heteroaryl derivatives of Formula (I) and pharmaceutically acceptable salts thereof. These compounds are useful in the treatment of RAGE-mediated diseases such as Alzheimer's Disease. The present invention further relates to methods for the preparation of compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds, and the use of such compounds and/or pharmaceutical compositions in treating RAGE-mediated diseases.